Marshfield Clinic Researchers Part of International Study
Thursday, September 11th, 2014 -- 11:13 AM
-Marshfield Clinic researchers are part of an international study, coordinated by the U.S. Food and Drug Administration, which has found that next-generation sequencing can work reliably across laboratories and find new gene variants.This work represents the largest effort to date to generate and analyze genes and reproduce findings, showing this is a valuable method for understanding and developing more specific therapies for medical disorders, especially cancer.
The study, reported by the Sequencing Quality Control consortium through Weill Cornell Medical College of New York, N.Y., is in print as of yesterday, in a special issue of the renowned scientific journal Nature Biotechnology.
Studies measuring gene activities as they respond to disease and therapy contribute substantially to biomedical research. This work, complementing existing technologies in clinical and pharmaceutical research and personalized medicine, allows doctors and scientists to get reliable, comparable analysis results. Project findings will now help prepare the FDA for the next wave of submission of genomic data.
Feel free to contact us with questions and/or comments.